Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Whitehawk Therapeutics (WHWK) Other Operating Expenses (2019 - 2025)

Whitehawk Therapeutics (WHWK) has disclosed Other Operating Expenses for 5 consecutive years, with -$177000.0 as the latest value for Q3 2025.

  • Quarterly Other Operating Expenses changed N/A to -$177000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $87.3 million through Dec 2025, changed N/A year-over-year, with the annual reading at $87.3 million for FY2025, N/A changed from the prior year.
  • Other Operating Expenses for Q3 2025 was -$177000.0 at Whitehawk Therapeutics, down from $87.4 million in the prior quarter.
  • The five-year high for Other Operating Expenses was $87.4 million in Q1 2025, with the low at -$177000.0 in Q3 2025.
  • Average Other Operating Expenses over 4 years is $15.4 million, with a median of $656000.0 recorded in 2023.
  • The sharpest move saw Other Operating Expenses plummeted 99.2% in 2022, then surged 317.57% in 2023.
  • Over 4 years, Other Operating Expenses stood at $74.2 million in 2021, then tumbled by 99.7% to $222000.0 in 2022, then surged by 317.57% to $927000.0 in 2023, then plummeted by 119.09% to -$177000.0 in 2025.
  • According to Business Quant data, Other Operating Expenses over the past three periods came in at -$177000.0, $87.4 million, and $927000.0 for Q3 2025, Q1 2025, and Q4 2023 respectively.